Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


US FDA and CMS to carry out parallel review of devices

This article was originally published in RAJ Devices

Executive Summary

The US Food and Drug Administration and the Centers for Medicare and Medicaid Services (CMS) are planning to establish a programme that would allow medical device companies to voluntarily apply for a joint evaluation of their products by the two agencies1. Once the modalities of the programme are finalised, the agencies intend to launch a pilot under which they will jointly review a small number of innovative devices.




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts